​

Funding Round

Series B - Moximed

Series B - Moximed

Investment Firm

Overview

Moximed develops innovative therapies for patients with knee osteoarthritis.

Announced Date

May 07, 2015

Closed on Date

Apr 09, 2015

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorGilde Healthcare
Participant InvestorGBS Ventures
Participant InvestorMorgenthaler Ventures
Participant InvestorVertex Ventures
Participant InvestorNew Enterprise Associates

Round Details and Background

Moximed raised $33000000 on 2015-05-07 in Series B

Moximed develops innovative therapies for patients with knee osteoarthritis.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 27, 2016
Series B - Moximed
3-12.6M
May 07, 2015
Series B - Moximed
6-33.0M
Jan 01, 2012
Venture Round - Moximed
4-1.8M
Dec 05, 2011
Series A - Moximed
-45.8M

Recent Activity

There is no recent news or activity for this profile.